Epidemiological state, patient’s characteristics, and COVID-19 vaccination levels in Algeria


  • Nour Chems El Houda Khennouchi
  • Laarem Meradi
  • Rania Hacini
  • Rahma Anfal Saighi
  • Manal Yahiaoui




SARS-CoV2, COVID-19, pandemic, vaccination, Oum El Bouaghi, Algeria


Since the global spread of the SARS-CoV-2 virus, responsible for COVID-19 disease, has been declared a “public health emergency of international concern” by the World Health Organization, epidemiological plans of control and investigation were established. In this study we aim to identify the epidemiological situation, mortality rates, and vaccination response in the population of Oum el Bouaghi, Algeria from March 2021 to March 2022. Clinical characteristics of COVID-19 confirmed cases, and vaccination data were collected from the Health and Population Directorate (HPD), as well as the COVID-19 unit in the Mohemed Boudiaf Public Hospital Establishment. The epidemiological profiles of the COVID-19 patients, along with cumulative number of people vaccinated depending on vaccine’s type were reported by numbers, percentages, curves and graphic histograms. The epidemiology of Covid-19 infection in Oum el Bouaghi, was similar to that recorded in many countries during the study period. It experienced two peaks, in August 2021 and in January 2022 which coincided with Delta and Omicron variants respectively. A total of 2068 COVID-19 cases were reported, with the average age of 54 and a female predominance (57%). Furthermore, people beyond the age of 40, especially over 65 years were the most hospitalized category (43% and 31% respectively), and presented the highest rate of morality (36% and 56% respectively).Among the 1510 hospitalized cases 169 (11%) patients passed away. They had a high profile of chronic diseases, especially cardiovascular diseases (high blood pressure/heart disease) 48% and diabetes 43%.Of a total of 84.047 people vaccinated, 59% were men, and 77% preferred Sinovac. People over 65 years had the highest vaccination rate (42%). People with chronic diseases accounted for 74% of the vaccinated population, clinicians and health professionals 7% and the rest of the population presented only 19%.In conclusion, People above 65 years with comorbidities appeared to be more susceptible to present the severe form of the infection. The quarantine adopted by Algeria and the strict precautionary measures has allowed the return to stability and a gradual reduction of positive cases. Additionally OEB had a medium participation in vaccination, with a dominance of people with chronic diseases. This perfectly meets the mechanism of COVAX and the indications of the Algerian High Authority of Health.


Masters, P. S., Perlman, S. (2013). Coronaviridae. In D. M. Knipe & P. M. Howley (Eds). Fields virology. (pp. 825-858). Philadelphia, PA, USA. Lippincott Williams & Wilkins.

Groot R., Baker S., Baric R., Enjuanes L., Gorbalenya A., Holmes, K., Perlman S., Poon L., Rottier P., Talbot P., Woo P., Ziebuhr, J. (2014). Coronaviridae. ICTV Ninth Report. Visited June 2nd, 2023. Available from : https://talk.ictvonline.org/ictv-reports/ictv_9th_report/positive-sense-rna-viruses-2011/w/posrna_viruses/222/coronaviridae

Mulabbi, E. N., Tweyongyere, R., & Byarugaba, D. K. (2021). The history of the emergence and transmission of human coronaviruses. The Onderstepoort journal of veterinary research, 88(1), e1–e8. https://doi.org/10.4102/ojvr.v88i1.1872

Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., & Tong, S. (2020). Epidemiology of COVID-19 Among Children in China. Pediatrics, 145(6), e20200702. https://doi.org/10.1542/peds.2020-0702

Ge, H., Wang, X., Yuan, X., Xiao, G., Wang, C., Deng, T., Yuan, Q., & Xiao, X. (2020). The epidemiology and clinical information about COVID-19. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology, 39(6), 1011–1019. https://doi.org/10.1007/s10096-020-03874-z

World Health Organization. Coronavirus (COVID-19) Dashboard. Visited July 26th, 2023. Available from : https://covid19.who.int/

Benzerga M. (03/2020). L’épidémie de coronavirus à Blida : Rues de plus en plus vides, hôpitaux dépassés. Visited June 4th, 2023. Available from : https://www.elwatan.com/edition/actualite/lepidemie-de-coronavirus-a-blida-rues-de-plus-en-plus-vides-hopitaux-depasses-18-03-2020

Hannouna D., Boughoufalah A., Meziani K., Aouchar N. (2022). Pandémie de Covid-19, Algérie- Situation épidémiologique du 21 janvier 2022. Institut National de Santé Publique. Bulletin épidémiologique, 257 (Jan 2022), 21p. https://www.insp.dz/images/evenements/Coronavirus/Bulletin_epidemiologique_N257_du_21_janvier_2022.pdf

Bonny, V., Maillard, A., Mousseaux, C., Plaçais, L., & Richier, Q. (2020). COVID-19 : physiopathologie d’une maladie à plusieurs visages [COVID-19: Pathogenesis of a multi-faceted disease]. La Revue de medecine interne, 41(6), 375–389. https://doi.org/10.1016/j.revmed.2020.05.003

Sharma, A., Ahmad Farouk, I., & Lal, S. K. (2021). COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses, 13(2), 202. https://doi.org/10.3390/v13020202

Desvaux, É., & Faucher, J. F. (2020). Covid-19 : aspects cliniques et principaux éléments de prise en charge [Covid-19: clinical aspects and management]. Revue francophone des laboratoires : RFL, 2020(526), 40–47. https://doi.org/10.1016/S1773-035X(20)30312-9

Hopkins, C., Surda, P., Whitehead, E., & Kumar, B. N. (2020). Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 49(1), 26. https://doi.org/10.1186/s40463-020-00423-8

World Health Organization. Coronavirus disease (COVID-19): Vaccine research and development (last update: 10 August 2021). Visited June 3rd, 2023. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccine-research-and-development

World Health Organization. COVAX: Working for global equitable access to COVID-19 vaccines. Visited June 6th, 2023. Available from: https://www.who.int/initiatives/act-accelerator/covax

Lounis M. (2021). Epidemiology of coronavirus disease 2020 (COVID-19) in Algeria. New microbes and new infections, 39, 100822. https://doi.org/10.1016/j.nmni.2020.100822

Office National des Statistiques, Statistiques Sociales. Visited June 6th, 2023. Available from: https://www.ons.dz/IMG/doc/demographie.doc

Le Monde avec AFP. (30/09/2021). En Algérie, lancement de la production locale du vaccin chinois CoronaVac contre le Covid-19. Visited June 8th, 2023. Available from: https://www.lemonde.fr/afrique/article/2021/09/30/en-algerie-lancement-de-la-production-locale-du-vaccin-chinois-coronavac-contre-le-covid-19_6096559_3212.html

Comité technique national consultatif sur la vaccination (CTNCV). (01/2021). Formation sur la vaccination contre la Covid-19. Visited June 8th, 2023. Available from: https://www.chu-mustapha.dz/wp-content/uploads/2021/02/5-Module-5-2-deroulement-de-la-seance-de-vaccination.pdf

Lam, H. Y., Lam, T. S., Wong, C. H., Lam, W. H., Leung, C. M. E., Au, K. W. A., Lam, C. K. Y., Lau, T. W. W., Chan, Y. W. D., Wong, K. H., & Chuang, S. K. (2020). The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong-January to May 2020. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 98, 51–58. https://doi.org/10.1016/j.ijid.2020.06.057

Khamis, F., Al Rashidi, B., Al-Zakwani, I., Al Wahaibi, A. H., & Al Awaidy, S. T. (2020). Epidemiology of COVID-19 Infection in Oman: Analysis of the First 1304 Cases. Oman medical journal, 35(3), e145. https://doi.org/10.5001/omj.2020.60

Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., Iotti, G., Latronico, N., Lorini, L., Merler, S., Natalini, G., Piatti, A., Ranieri, M. V., Scandroglio, A. M., Storti, E., Cecconi, M., … COVID-19 Lombardy ICU Network (2020). Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA, 323(16), 1574–1581. https://doi.org/10.1001/jama.2020.5394

Cataño-Correa, J. C., Cardona-Arias, J. A., Porras-Mancilla, J. P., & Tabares-García, M. (2022). Comparison of Survival and Clinical Profile of Adults with COVID-19 Hospitalized in Two Clinics in Medellín, Colombia. Current clinical microbiology reports, 9(2), 11–19. https://doi.org/10.1007/s40588-022-00179-x

Raman, R., Patel, K. J., & Ranjan, K. (2021). COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies. Biomolecules, 11(7), 993. https://doi.org/10.3390/biom11070993

Zhang, W., Davis, B. D., Chen, S. S., Sincuir Martinez, J. M., Plummer, J. T., & Vail, E. (2021). Emergence of a Novel SARS-CoV-2 Variant in Southern California. JAMA, 325(13), 1324–1326. https://doi.org/10.1001/jama.2021.1612

Choi, J. Y., & Smith, D. M. (2021). SARS-CoV-2 Variants of Concern. Yonsei medical journal, 62(11), 961–968. https://doi.org/10.3349/ymj.2021.62.11.961

Araf, Y., Akter, F., Tang, Y. D., Fatemi, R., Parvez, M. S. A., Zheng, C., & Hossain, M. G. (2022). Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. Journal of medical virology, 94(5), 1825–1832. https://doi.org/10.1002/jmv.27588

Ward, I. L., Bermingham, C., Ayoubkhani, D., Gethings, O. J., Pouwels, K. B., Yates, T., Khunti, K., Hippisley-Cox, J., Banerjee, A., Walker, A. S., & Nafilyan, V. (2022). Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study. BMJ (Clinical research ed.), 378, e070695. https://doi.org/10.1136/bmj-2022-070695

Jayaraj, V. J., Rampal, S., Ng, C. W., & Chong, D. W. Q. (2021). The Epidemiology of COVID-19 in Malaysia. The Lancet regional health. Western Pacific, 17, 100295. https://doi.org/10.1016/j.lanwpc.2021.100295

Chandrasekaran, B., & Ganesan, T. B. (2021). Sedentarism and chronic disease risk in COVID 19 lockdown - a scoping review. Scottish medical journal, 66(1), 3–10. https://doi.org/10.1177/0036933020946336

Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. The Lancet. Respiratory medicine, 8(4), e21. https://doi.org/10.1016/S2213-2600(20)30116-8

Jin, L., Li, Z., Zhang, X., Li, J., & Zhu, F. (2022). CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2. Human vaccines & immunotherapeutics, 18(6), 2096970. https://doi.org/10.1080/21645515.2022.2096970

Abdelmoneim, S. A., Sallam, M., Hafez, D. M., Elrewany, E., Mousli, H. M., Hammad, E. M., Elkhadry, S. W., Adam, M. F., Ghobashy, A. A., Naguib, M., Nour El-Deen, A. E., Aji, N., & Ghazy, R. M. (2022). COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis. Tropical medicine and infectious disease, 7(10), 298. https://doi.org/10.3390/tropicalmed7100298

Ghazy, R. M., Abdou, M. S., Awaidy, S., Sallam, M., Elbarazi, I., Youssef, N., Fiidow, O. A., Mehdad, S., Hussein, M. F., Adam, M. F., Abdullah, F. S. A., Rebai, W. K., Raad, E. B., Hussein, M., Shehata, S. F., Ismail, I. I., Salam, A. A., & Samhouri, D. (2022). Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. International journal of environmental research and public health, 19(19), 12136. https://doi.org/10.3390/ijerph191912136

Zaçe, D., La Gatta, E., Petrella, L., & Di Pietro, M. L. (2022). The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis. Vaccine, 40(42), 6023–6034. https://doi.org/10.1016/j.vaccine.2022.09.019

Diaz, P., Zizzo, J., Balaji, N. C., Reddy, R., Khodamoradi, K., Ory, J., & Ramasamy, R. (2022). Fear about adverse effect on fertility is a major cause of COVID-19 vaccine hesitancy in the United States. Andrologia, 54(4), e14361. https://doi.org/10.1111/and.14361




How to Cite

Khennouchi, N. C. E. H., Meradi, L., Hacini, R., Saighi, R. A., & Yahiaoui, M. (2023). Epidemiological state, patient’s characteristics, and COVID-19 vaccination levels in Algeria. South Florida Journal of Health, 4(1), 225–240. https://doi.org/10.46981/sfjhv4n1-018